Vascular endothelial growth factor levels in post-CABG pleural effusions are associated with pleural inflammation and permeability

Respiratory Medicine

Volumn 101, Issue 2, 2007, Pages 223-229

  Kalomenidis, Ioannis ^a   Stathopoulos, Georgios T ^b   Barnette, Randal ^b   Papiris, Spyros ^c   Blackwell, Timothy S ^b   Roussos, Charis ^a   Light, Richard W ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b VANDERBILT UNIVERSITY   (United States)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Pleural effusion; Pleural inflammation; Post coronary artery by pass grafting; Vascular endothelial growth factor

Indexed keywords

LACTATE DEHYDROGENASE; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; PATHOGENESIS; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE; THORACOCENTESIS;

CELL COUNT; CORONARY ARTERY BYPASS; HUMANS; PERMEABILITY; PLEURA; PLEURAL EFFUSION; PLEURISY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846166420     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.05.018     Document Type: Article

References (23)

1. Light R.W. Pleural effusions after coronary artery bypass graft surgery. Curr Opin Pulm Med 8 (2002) 308-311
2. Light R.W., Rogers J.T., Moyers J.P., et al. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med 166 (2002) 1567-1571
3. Sadikot R.T., Rogers J.T., Cheng D.S., et al. Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. Arch Intern Med 160 (2000) 2665-2668
4. Grove C.S., and Lee Y.C.G. Vascular endothelial growth factor: the key mediator in pleural effusion formation. Curr Opin Pulm Med 8 (2002) 294-301
5. Cheng D., Rodriguez R.M., Perkett E.A., et al. Vascular endothelial growth factor in pleural fluid. Chest 116 (1999) 760-765
6. Hamed E.A., El-Noweihi A.M., Mohamed A.Z., et al. Vasoactive mediators (VEGF and TNF-α) in patients with malignant and tuberculous pleural effusions. Respirology 9 (2004) 81-86
7. Momi H., Matsuyama W., Inoue K., et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med 96 (2002) 817-822
8. Sack U., Hoffman M., Zhao X.J., et al. Vascular endothelial growth factor in pleural effusions of different origin. Eur Respir J 25 (2005) 600-604
9. Ruiz E., Aleman C., Alegre J., et al. Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions. Lung 183 (2005) 185-195
10. Kalomenidis I., Kollintza A., Sigala I., et al. Angiopoeitin-2 levels are elevated in exudative pleural effusions. Chest 129 (2006) 259-266
11. Kalomenidis I., Stathopoulos G.T., Barnette R., et al. Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions. Chest 127 (2005) 2094-2100
12. Lee Y.C.G., and Lane K.B. Cytokines in pleural diseases. In: Light R.W., and Lee Y.C.G. (Eds). Textbook of pleural disease (2003), Arnold, London, UK 63-89
13. Cheng D., Lee Y.C.G., Rogers J.T., et al. Vascular endothelial growth factor level correlates with transforming growth-β isoform levels in pleural effusions. Chest 118 (2000) 1747-1753
14. Yano S., Shinohara H., Herbst R.S., et al. Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am J Pathol 157 (2000) 1893-1903
15. Yano S., Herbst R.S., Shinohara H., et al. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Clin Cancer Res 6 (2000) 957-965
16. Zhu Z., Stathopoulos G.T., Dikensoy O., et al. The efficacy of SU11248 in inhibition of tumor growth and pleural fluid formation in a mouse malignant pleural effusion model. Proc Am Thorac Soc 2 (2005) A536
17. Ishimoto O., Saiijo Y., Kimura Y., et al. High level of vascular endothelial growth factor in hemorrhagic pleural effusion of cancer. Oncology 63 (2002) 70-75
18. Luo J.C., Toyoda M., and Shibuya M. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Cancer Res 15 58 (1998) 2594-2600
19. Thurston G. Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage. J Anat 200 (2002) 575-580
20. Strizzi L., Catalano A., Vianale G., et al. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193 (2001) 468-475
21. Kraft A., Weindel K., Ochs A., et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85 (1999) 178-187
22. Kiropoulos T.S., Kostikas K., and Gourgoulianis K.I. Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions. Chest 128 (2005) 468
23. Pichelmayer O., Zielinski C., and Raderer M. Response of a nonmalignant pleural effusion to bevacizumab. N Engl J Med 18 353 (2005) 740-741